Recently Viewed 0
Meet Clearsynth at CPHI Milan · October 6–8, 2026 · Booth 10F24 Book a meeting
My Account Need quick assistance? WhatsApp us +91-22-45045900 sales@clearsynth.com
Home Everolimus Impurity CS-T-77815

Everolimus Retroaldol Degradation Product

Enquire

Everolimus Retroaldol Degradation Product

Impurity · API Family: Everolimus · CAT No. CS-T-77815 · CAS No. 1708118-13-1
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Clearsynth product packaging

Packaging & Handling

Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.

Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.

Everolimus Retroaldol Degradation Product Product Information

Everolimus Retroaldol Degradation Product is listed under Impurity and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Everolimus. The product is supplied by Clearsynth under CAT No. CS-T-77815.

Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.

Technical Data

Product Name
Everolimus Retroaldol Degradation Product
CAS No.
1708118-13-1
CAT No.
CS-T-77815
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C53H83NO14
Molecular Weight
958.2
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.

Description

Regulatory Description
Everolimus Retroaldol Degradation Product is supplied with detailed characterization data compliant with regulatory guideline. Everolimus Retroaldol Degradation Product can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Everolimus.
Overview
Everolimus Retroaldol Degradation Product is an impurity of Everolimus. Everolimus is a derivative of Rapamycin. Everolimus inhibits cytokine-mediated lymphocyte proliferation.
Synonyms
Everolimus Retroaldol Degradation Product
Application Notes
Everolimus Retroaldol Degradation Product is an impurity of Everolimus. Everolimus is a derivative of Rapamycin. Everolimus inhibits cytokine-mediated lymphocyte proliferation.
References

Product Applications & Regulatory Search Terms

Useful product, supplier and regulatory search terms for this reference standard.

Buy 1708118-13-1Purchase 1708118-13-1Order 1708118-13-1Enquire 1708118-13-1Price of 1708118-13-11708118-13-1 Supplier1708118-13-1 Manufacturer1708118-13-1 ExporterBuy high quality Everolimus Retroaldol Degradation ProductPurchase Everolimus Retroaldol Degradation ProductEverolimus Retroaldol Degradation Product SuppliersEverolimus Retroaldol Degradation Product ManufacturersEverolimus Retroaldol Degradation Product PriceOrder Everolimus Retroaldol Degradation ProductEnquire Everolimus Retroaldol Degradation ProductEverolimus Retroaldol Degradation Product CostEverolimus Retroaldol Degradation Product SupplierEverolimus Retroaldol Degradation Product DistributorEverolimus Retroaldol Degradation Product for Method ValidationEverolimus Retroaldol Degradation Product for ANDA FilingEverolimus Retroaldol Degradation Product for Forced Degradation StudiesEverolimus Retroaldol Degradation Product Identification StandardsEverolimus Retroaldol Degradation Product for DMF FilingEverolimus Reference Standard
Downloading MSDS…
Done
Done
RFQ Basket 0
Done
RFQ Basket 0
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.